WARFARIN VS DOACS IN A REAL-WORLD DATA

被引:0
|
作者
Carmi, O. [1 ]
Madjar, T. [1 ]
Hornik-Lurie, T. [2 ]
机构
[1] Meir Med Ctr, Rheumatol, Kefar Sava, Israel
[2] Meir Med Ctr, Stat, Kefar Sava, Israel
关键词
Real-world evidence; Anti-phospholipid syndrome;
D O I
10.1136/annrheumdis-2023-eular.6069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS1157
引用
收藏
页码:910 / 910
页数:1
相关论文
共 50 条
  • [1] Pharmacogenetics of warfarin and healthcare costs - Real-world data analysis
    Lahteenmaki, Jaakko
    Vuorinen, Anna-Leena
    Lehto, Mika
    Niemi, Mikko
    Forsberg, Markus M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (03) : 382 - 386
  • [3] Population Impact of Drug Interactions with Warfarin: A Real-World Data Approach
    Martin-Perez, Mar
    Gaist, David
    de Abajo, Francisco J.
    Garcia Rodriguez, Luis A.
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (03) : 461 - 470
  • [4] Real-World Battles with Real-World Data
    Brown, Jeffrey
    Bate, Andrew
    Platt, Robert
    Raebel, Marsha
    Sauer, Brian
    Trifiro, Gianluca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 254 - 255
  • [5] Real-world evidence that among atrial fibrillation patients warfarin is associated with reduced nonelective admissions compared with those on DOACs
    Yu, Dahai
    Brown, Julian
    Strain, W. David
    Simmons, David
    CLINICAL CARDIOLOGY, 2023, 46 (12) : 1544 - 1553
  • [6] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [7] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [9] REAL-WORLD DATA
    STROCK, JM
    POLICY REVIEW, 1993, 63 : 96 - 96
  • [10] Data Science Methods for Real-World Evidence Generation in Real-World Data
    Liu, Fang
    ANNUAL REVIEW OF BIOMEDICAL DATA SCIENCE, 2024, 7 : 201 - 224